Home » News » Mainz is exploring further areas for a biotech position

Mainz is exploring further areas for a biotech position

New biotechnological center Mainz is exploring further areas for a biotech position

04.05.2022Source: dpa

Since Biontech’s success, Mainz has been considered the world’s pharmacy. Now the state capital will become a major international biotech location. But not just her.

suppliers on the matter

The Rhein-Nahe-Hunsrück regional initiative aims to develop the “Milden West” – between Birkenfeld and Mainz – in the Biotech Valley together with chambers and universities.

(Image: Biotechnology)

Mainz – The city of Mainz has provided an additional 50 hectares of planned land for its planned expansion into an international biotech location. A competition of urban planning ideas for this predominantly agricultural area is expected to begin this year, Mayor Michael Ebling and Marianne Grosse (both SPDs) reported in Mainz on Tuesday. “In the long run, we need more space,” Grosse said in the justification.

According to the regional initiative Rhein-Nahe-Hunsrück, the development of biotechnology has potential even beyond Mainz. Together with chambers and universities, he wants to develop the “Mild West” – between Birkenfeld and Mainz – in the “Biotech Valley”. Together with the Technical University of Bingen and the Birkenfeld Environmental Campus of the University of Trier, a study is being developed to show the foundations.

The international competition for urban planning ideas of the city of Mainz, in stages, is expected to end in the course of the next year. Most of the designated areas are privately owned, and the city property management company is looking into the willingness to sell, Grosse said. A microclimatic assessment will accompany the competition. “Cold air corridors and climatic conditions play a fundamental role.” However, an initial assessment still considers urban development in the area west of the university to be possible. The exact need for what is to be built is currently being determined. The public will be involved as soon as possible.

Over the next ten years, Mainz expects some 5,000 new jobs in biotechnology and an estimated investment volume of one billion euros, Ebling recalled. “The numbers are becoming more realistic by the day and will likely be revised upwards in a few years,” she said. For this, an area of ​​30 hectares has already been selected, independent of the planning area of ​​50 hectares.

Corporate projects for vaccines and drugs against Covid-19 in Germany, Austria and Switzerland.  (VFA)

The 30 hectares consist of twelve hectares on the site of a former barracks in the immediate vicinity of Biontech, the university hospital and the non-profit research institute Tron. According to plans presented on Monday by the state government and Biontech boss Ugur Sahin, this will be expanded to around 200 million euros by 2025. The city wants new technologies to be developed and prepared for market on the twelve-hectare site. There are also 18 hectares of commercial area near the university. This can likely be developed by August, and construction can begin six months later, Ebling said.

Starting April 15, 2021

It goes without saying that we treat your personal data responsibly. If we collect personal data from you, we process it in accordance with applicable data protection regulations. You can find detailed information in our data protection declaration.

Consent to use of data for advertising purposes

I agree that Vogel Communications Group GmbH & Co. KG, Max-Planckstr. 7-9, 97082 Würzburg, including all affiliated companies pursuant to §§ 15 et seq. AktG (hereinafter: Vogel Communications Group) uses my e-mail address for sending editorial newsletters. Lists of respective related companies may here be recovered.

The content of the newsletter extends to the products and services of all the companies mentioned above, including, for example, trade journals and trade books, events and fairs, as well as products and services relating to events, offers and services of print and digital media as well as others newsletters (editorial), competitions, lead campaigns, market research in the online and offline area, thematic web portals and e-learning offers. If my personal telephone number has also been collected, it can be used for the submission of offers for the aforementioned products and services by the aforementioned companies and for market research.

If I call up protected content on the portals of Vogel Communications Group, including affiliated companies pursuant to §§ 15 and following AktG, I have to register with additional data to access this content. In exchange for this free access to editorial content, my data may be used in accordance with this consent for the purposes indicated here.

right of revocation

I am aware that I can withdraw this consent at any time for the future. My revocation does not affect the lawfulness of the processing carried out on the basis of my consent up to the time of revocation. To explain my revocation, I can use the following as an option https://support.vogel.de use the contact form available. If I no longer wish to receive the individual newsletters I have subscribed to, I can also click on the unsubscribe link at the end of a newsletter. I can find more information about my right of withdrawal and how to exercise it, as well as the consequences of my withdrawal, in the data protection declaration, section Editorial newsletters.

(ID: 48285678)

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.